People · Operator
Named in public records as an officer, director or promoter · active 2018–2025 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| FreMon Scientific, Inc. | — | Other Health Care | Seed | $4.1M | $52.2M | 2018 |
| Carna Inc. | — | Biotechnology | Seed | $3.4M | $12.4M | 2025 |
Salvatore Viscomi at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Salvatore Viscomi on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Joseph Cohen | 1 | 7 |
| Thomas Dolan | 1 | 4 |
| David Vogel | 1 | 2 |
| Farideh Bischoff | 1 | 2 |
| Michelle Longmire | 1 | 2 |
| Mary Sallah | 1 | 1 |
| Boris Berat | 1 | 1 |
| Menachem Shavit | 1 | 1 |
| Thomas Rosenbloom | 1 | 1 |
| Fred Thacher | 1 | 1 |
| Frederick Thacher | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.